超声波技术
Search documents
上海骄成超声波技术股份有限公司2025年度业绩快报公告
Shang Hai Zheng Quan Bao· 2026-02-27 20:36
证券代码:688392 证券简称:骄成超声 公告编号:2026-006 上海骄成超声波技术股份有限公司2025年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 二、经营业绩和财务状况情况说明 (一)报告期的经营情况、财务状况及影响经营业绩的主要因素 1、经营情况、财务情况 报告期内,公司实现营业收入77,401.45万元,比上年同期增长32.41%;实现归属于母公司所有者的净 利润11,491.73万元,比上年同期增长33.83%;实现归属于母公司所有者的扣除非经常性损益的净利润 9,231.84万元,比上年同期增长132.50%。 报告期末,公司总资产237,058.57万元,较本报告期初增长11.54%;归属于母公司的所有者权益 179,903.52万元,较本报告期初增长6.36%。 本公告所载上海骄成超声波技术股份有限公司(以下简称"公司")2025年度主要财务数据为初步核算数 据,未经会计师事务所审计,具体数据以公司2025年度的定期报告为准,提请投资者注意投资风险。 一、2025年度主要财务数据和 ...
骄成超声:及时响应客户需求,持续深耕海外市场
Zheng Quan Ri Bao Zhi Sheng· 2026-01-20 12:09
Core Viewpoint - The company, Jiao Cheng Ultrasonic, is focusing on expanding its overseas business, particularly in the European market, with an expected revenue contribution of approximately 1% from overseas operations in 2024 [1]. Group 1: Business Strategy - The company is dedicated to the research and application of ultrasonic technology, aiming to create a comprehensive technology platform that covers both power ultrasound and detection ultrasound [1]. - The company is actively promoting high-end applications in the fields of new energy and semiconductors, specifically targeting products such as harness connector ultrasonic equipment and semiconductor ultrasonic equipment [1]. Group 2: Market Expansion - The company is leveraging its domestic factories to export products to the European market while also utilizing overseas subsidiaries or channel partnerships to promote its products in Europe and other international regions [1]. - The company emphasizes its commitment to responding promptly to customer needs and continuously deepening its presence in overseas markets [1].
公司问答丨骄成超声:公司产品主要应用于新能源、半导体等领域 并持续拓展超声波技术在半导体先进封装、医疗等领域的应用
Ge Long Hui A P P· 2026-01-14 09:08
Core Viewpoint - The company is focused on the research and application of ultrasonic technology, aiming to build a comprehensive technology platform that covers both power ultrasound and detection ultrasound [1] Group 1: Company Strategy - The company is leveraging its core ultrasonic technology to expand into various fields, including new energy and semiconductors [1] - The company emphasizes strong R&D investment to continuously enhance its professional technology platform and core competitiveness [1] Group 2: Product Applications - The company's products are primarily applied in the new energy and semiconductor sectors [1] - The company is actively exploring the application of ultrasonic technology in advanced semiconductor packaging and medical fields [1]
陈天桥再次押注!中国首家超声脑机接口公司格式塔 Gestala 正式成立,开启全脑读写脑机接口时代
Sou Hu Wang· 2026-01-05 05:06
Core Viewpoint - Gestala (Chengdu) Technology Co., Ltd. has officially launched as China's first company focused on ultrasound brain-machine interface technology, aiming to provide innovative solutions for brain disease treatment and neuroscience research through non-invasive ultrasound technology [1][2][3]. Company Overview - Gestala was co-founded by Peng Lei, former co-founder and CEO of Brain Tiger Technology, and Chen Tianqiao, founder of Shanda Group and Tianqiao Brain Science Research Institute, focusing on the innovation of ultrasound brain-machine interface technology [3][5]. - The company is located in Chengdu's Tianfu International Biological City and has also established a presence in Shanghai's Brain Intelligence World, a hub for brain-machine interface industries [3]. Technology and Applications - Gestala's ultrasound technology features non-invasive, high spatiotemporal resolution, and full-brain coverage, targeting clinical interventions for central nervous system diseases such as chronic pain, depression, and Alzheimer's disease [1][6]. - The ultrasound brain-machine interface is expected to enable precise modulation of specific brain regions without the need for surgery, allowing for innovative treatments and exploration of new targets for related brain diseases [6][8]. - The company plans to launch its first magnetic resonance-guided device for chronic pain management and initiate the NMPA registration process by the end of 2026 [8]. Clinical Collaborations and Research - Gestala has established collaborative frameworks with top hospitals such as Huashan, Xiehe, and Huaxi, aiming to deepen the synergy between industry, academia, and clinical research [8][11]. - The company has reported significant clinical intervention results in chronic pain management and depression, with effects lasting up to seven days after treatment [8]. Market Potential and Competitive Landscape - The global ultrasound brain-machine interface financing boom positions China to potentially "leapfrog" in this field, with significant investments flowing into ultrasound technology as a disruptive alternative to invasive methods [9][10]. - The ultrasound route is gaining traction due to its ability to cover 25% of the brain volume, compared to traditional invasive methods that are limited to localized areas [7][11]. - Gestala's interdisciplinary team includes experts from neuroscience, AI, ultrasound engineering, and clinical medicine, enhancing its capability for research breakthroughs and clinical applications [11].
骄成超声(688392):超声波平台型公司,持续打造多维成长曲线
CMS· 2025-12-29 08:06
Investment Rating - The report initiates coverage with an "Accumulate" investment rating for the company [1][3]. Core Views - The company is a rare platform-type entity in the A-share market, mastering the underlying technology of ultrasound and continuously advancing applications in various segments, including lithium batteries, semiconductor advanced packaging, and medical aesthetics. This platform capability provides resilience across economic cycles, with the second growth curve already beginning to materialize [1][7][14]. - The company is positioned to replicate its growth trajectory in the lithium battery sector within the advanced packaging equipment market, driven by strong domestic demand for localization [7][21]. Financial Data and Valuation - The company forecasts total revenue growth from 5.25 billion CNY in 2023 to 15.32 billion CNY in 2027, with year-on-year growth rates of 34% and 40% for 2025 and 2026 respectively [2][8]. - The net profit attributable to shareholders is expected to rise from 670 million CNY in 2023 to 3.81 billion CNY in 2027, with significant growth rates of 76% and 64% for 2025 and 2026 respectively [2][8]. - The company's price-to-earnings (PE) ratio is projected to decrease from 206.9 in 2023 to 36.2 by 2027, indicating improving valuation metrics as earnings grow [2][8]. Company Overview - The company has been a leader in the domestic ultrasound equipment market for nearly 20 years, with a comprehensive ultrasound technology platform that supports various industries, including lithium batteries, photovoltaic energy storage, semiconductors, automotive wiring, and medical aesthetics [7][34]. - The company has established a stable revenue stream from consumables, which accounted for 31.42% of total revenue in 2024, reflecting a strong business model that combines equipment sales with high-margin consumables [34][30]. Growth Curves - The first growth curve is driven by the recovery in capital expenditures in the lithium battery sector, with new technologies like solid-state batteries creating additional demand for equipment [18][21]. - The second growth curve focuses on advanced packaging equipment, where the company has secured orders and is positioned to lead in domestic market share [21][22]. - The third growth curve involves strategic expansion into the medical aesthetics sector, with significant market potential anticipated in the coming years [21][22]. Profitability and Financial Performance - The company has shown a compound annual growth rate (CAGR) of 32.32% in revenue from 2018 to 2024, with a notable recovery in profitability expected as market conditions improve [39][42]. - The gross margin for consumables is projected to reach 75.93% in 2024, significantly higher than the overall product margins, contributing to enhanced profitability [27][30]. - The company maintains a high research and development expenditure rate, which supports its long-term growth strategy and technological advancements [51].
紧跟国内半导体产业升级发展需求和技术发展趋势,泉果基金调研骄成超声
Xin Lang Cai Jing· 2025-11-25 06:22
Core Insights - The article discusses the recent research conducted by QuanGuo Fund on the listed company JiaoCheng Ultrasonic, highlighting the fund's performance and the company's competitive advantages in the ultrasonic technology sector. Group 1: Fund Performance - QuanGuo Fund was established on February 8, 2022, and currently manages assets totaling 23.787 billion yuan across six funds with five fund managers [1] - The best-performing fund in the past year is QuanGuo XuYuan Three-Year Holding Mixed A (016709), achieving a return of 31.08% [1] - Other notable fund performances include: - QuanGuo XuYuan Three-Year Holding Mixed C (30.56%) - QuanGuo Consumer Opportunity Mixed Initiation A (25.79%) - QuanGuo SiYuan Three-Year Holding Mixed A (24.23%) - QuanGuo JiaYuan Three-Year Holding Mixed A (20.47%) [1] Group 2: Company Product Applications - The company’s ultrasonic technology encompasses both power ultrasound and detection ultrasound, with applications in new energy batteries, wiring connectors, and semiconductors [1] - The ultrasonic equipment varies significantly in frequency, power, and precision, indicating a wide range of technical challenges [1] Group 3: R&D Advantages - The company possesses the capability to independently produce core components of ultrasonic systems, giving it a competitive edge in technology innovation and talent resources [2] - Close collaboration with well-known clients allows the company to anticipate market demands and focus on developing new technologies and products [2] Group 4: Semiconductor Sector Competition - The company offers a full range of ultrasonic solutions, including ultrasonic terminal welding machines and ultrasonic scanning microscopes, and has established partnerships with major enterprises [3] - The domestic market for core ultrasonic equipment in semiconductor packaging remains underdeveloped, with a high market share held by imported equipment [3] - The company is gradually increasing its market share by leveraging its technological expertise to challenge foreign competitors [3] Group 5: Profitability Metrics - For the fiscal year 2024, the gross profit margin for the company's semiconductor ultrasonic equipment is projected to be 56.65% [4] - Continuous optimization of product structure and operational efficiency is aimed at enhancing overall competitiveness [4] Group 6: Technical Barriers - The application of ultrasonic technology involves multiple disciplines, creating significant technical barriers due to the complexity of maintaining ideal resonance states and minimizing operational losses [5] Group 7: Academic Collaborations - The company has signed an agreement with Shanghai Jiao Tong University to establish a joint laboratory focused on advanced semiconductor packaging and intelligent robotics [6] - This collaboration aims to advance research in ultrasonic precision detection technology and promote talent development and technology transfer [6]
骄成超声(688392):25Q3点评:业绩持续高增,平台化布局渐成
Changjiang Securities· 2025-11-07 08:44
Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Insights - The company benefits from the growth in downstream demand from lithium batteries, wiring harnesses, and semiconductors, leading to a year-on-year revenue increase. The optimization of product structure and continuous improvement in quality and efficiency have resulted in sustained profit release, aligning with expectations. The company is deeply engaged in ultrasonic technology across new energy, semiconductors, and medical fields, with strong platform capabilities and long-term growth potential. Additionally, the equipment and consumables model is superior, enhancing profitability. The report is optimistic about the company's platform development and the "equipment + consumables" business model [2][12]. Summary by Sections Financial Performance - In the first three quarters of 2025, the company achieved revenue of 521 million yuan, a year-on-year increase of 27.53%. The net profit attributable to the parent company was 94 million yuan, up 359.81%. In Q3 2025, revenue reached 198 million yuan, growing by 20.16%, with a net profit of 36 million yuan, an increase of 136.81% [6][12]. Business Segments - The traditional lithium battery segment shows significant recovery, with strong growth expectations for new orders. The semiconductor business is thriving, with multiple models of advanced ultrasonic scanning microscopes achieving order deliveries, breaking foreign monopolies. The company has also developed ultrasonic welding and additive manufacturing equipment for aerospace applications and high-precision ultrasonic detection equipment for liquid cooling plates, enhancing its market presence [12][12]. Future Projections - The company is expected to achieve net profits of 146 million yuan and 240 million yuan in 2025 and 2026, respectively, corresponding to price-to-earnings ratios of 92 and 56 times. The long-term growth potential remains strong due to the company's focus on ultrasonic technology and its ability to expand into new markets [12][12].
山西证券研究早观点-20251024
Shanxi Securities· 2025-10-24 01:00
Group 1: Market Trends - The domestic coal price increased in September 2025, leading to a rise in coal imports, with a month-on-month increase of 7.63% despite a year-on-year decrease of 3.34% [5] - The overall market indices showed slight increases, with the Shanghai Composite Index closing at 3,922.41, up 0.22% [2] Group 2: Coal Industry Insights - The coal import volume continued to show a contraction trend, with a cumulative year-on-year decrease of 11.1% from January to September 2025, although the rate of decline is slowing [5] - The domestic coal price is expected to support import demand due to a persistent domestic supply gap, with the price difference between domestic and imported coal likely to widen [5] - Investment opportunities in the coal sector are anticipated for Q4 2025, with expectations of better performance compared to Q3 [5] Group 3: Communication Industry Developments - Broadcom launched the first 800G AI Ethernet network interface card, Thor Ultra, which supports advanced AI networking capabilities [6] - The introduction of the 102.4T CPO switch, TH6-Davisson, is expected to mark 2026 as a significant year for CPO scale shipments, enhancing link stability and energy efficiency [6] - The ESUN Ethernet supernode alliance was introduced, aiming to challenge proprietary high-speed interconnect markets in AI clusters [7] Group 4: Agricultural Sector Analysis - Wens Foodstuff Group reported a year-on-year increase in pig sales by 28.32% for the first three quarters of 2025, with a total of 27.67 million pigs sold [11] - The company’s chicken sales for the same period reached 948 million, reflecting a year-on-year growth of 8.9% [12] Group 5: Tire Industry Overview - Taike Ying specializes in the design and production of tires for mining and construction, with a significant increase in production and export rates from 2016 to 2022 [14] - The company is recognized as a national-level "specialized and innovative" small giant, focusing on user-specific product development [14] Group 6: Ultrasonic Technology Sector - The ultrasonic technology platform company has seen significant growth in revenue, with a 32.5% year-on-year increase in the first half of 2025 [17] - The company is expanding its applications in various sectors, including lithium batteries and semiconductors, benefiting from the acceleration of domestic production [20]
骄成超声(688392):超声波技术平台型企业,多领域布局迎来突破
Shanxi Securities· 2025-10-23 08:45
Investment Rating - The report maintains a "Buy-A" rating for the company [6] Core Insights - The company is a domestic ultrasonic technology platform enterprise with diversified business growth, focusing on applications in various sectors such as power batteries, semiconductors, automotive, and tires [2][16] - In the first half of 2025, the company achieved revenue of 323 million yuan, a year-on-year increase of 32.50%, and a significant increase in net profit attributable to the parent company [2][27] - The company has maintained a research and development expense ratio exceeding 20% for two consecutive years, leading to technological breakthroughs and business expansion [2][23] Summary by Sections 1. Ultrasonic Technology Platform Enterprise - The company has established a comprehensive ultrasonic technology platform since its founding in 2007, providing solutions for various industries [16] - The actual controller has a strong technical background and has led the company to maintain high R&D investment [19][23] - The company’s revenue in 2024 was 585 million yuan, with a year-on-year growth of 11.30%, and the first half of 2025 showed a continued upward trend [27] 2. Lithium Battery Business - The lithium battery business benefits from downstream recovery and technological changes, with significant demand from leading manufacturers like CATL and BYD [2][39] - The company’s ultrasonic welding technology has distinct advantages over traditional methods, particularly in multi-layer ear welding [36] - The company is positioned as a key supplier for major battery manufacturers, enhancing its market competitiveness [39][40] 3. Semiconductor and Automotive Business - The semiconductor and automotive sectors are experiencing rapid growth due to domestic production acceleration, with the wire harness business expected to grow significantly [3][4] - The company provides comprehensive ultrasonic application solutions for the semiconductor market, benefiting from increased domestic production rates [3][4] 4. Parts and Consumables Business - The company has a high self-manufacturing rate for key components, providing stable cash flow from its consumables business [3][5] - The consumables business is expected to grow steadily as the installed base of equipment increases across various industries [3][5] 5. Profit Forecast and Valuation Analysis - The company is expected to see net profits of 137 million yuan, 212 million yuan, and 305 million yuan from 2025 to 2027, with corresponding year-on-year growth rates of 59.5%, 54.7%, and 43.8% [6][8] - The projected EPS for the same period is 1.18 yuan, 1.83 yuan, and 2.63 yuan, with a PE ratio of 96, 62, and 43 times respectively [6][8]
【私募调研记录】正圆投资调研骄成超声
Zheng Quan Zhi Xing· 2025-08-21 00:13
Group 1 - The core viewpoint of the news is that the company Jiao Cheng Ultrasonic is experiencing improvements in gross profit margin due to changes in product structure and enhanced management efficiency, with a focus on the semiconductor advanced packaging sector [1] - Jiao Cheng Ultrasonic has received orders and has begun mass shipments of various ultrasonic equipment, indicating a positive trend in their business operations [1] - The company has a strong R&D team, which provides a competitive advantage and core competencies in the market [1] Group 2 - The company has seen a recovery in orders for its new energy battery equipment business after facing challenges last year [1] - Ultrasonic welding equipment is being utilized for solid-state battery ear welding, with small batch orders already delivered [1] - The company is expanding its applications of ultrasonic technology across various sectors, including new energy batteries, wiring harness connectors, and semiconductors [1]